Cargando…

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response

The treatment and management of patients with metastatic melanoma have evolved considerably in the “era” of personalized medicine. Melanoma was one of the first solid tumors to benefit from immunotherapy; life expectancy for patients in advanced stage of disease has improved. However, many progresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenti, Fabio, Falcone, Italia, Ungania, Sara, Desiderio, Flora, Giacomini, Patrizio, Bazzichetto, Chiara, Conciatori, Fabiana, Gallo, Enzo, Cognetti, Francesco, Ciliberto, Gennaro, Morrone, Aldo, Guerrisi, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067863/ https://www.ncbi.nlm.nih.gov/pubmed/33917181 http://dx.doi.org/10.3390/ijms22083837

Ejemplares similares

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
por: Ricciardi, Elena, et al.
Publicado: (2023)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
por: Falcone, Italia, et al.
Publicado: (2020)

Artificial Intelligence and Advanced Melanoma: Treatment Management Implications
por: Guerrisi, Antonino, et al.
Publicado: (2022)

Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach
por: Guerrisi, Antonino, et al.
Publicado: (2021)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
por: Conciatori, Fabiana, et al.
Publicado: (2019)

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy
por: Conciatori, Fabiana, et al.
Publicado: (2020)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition
por: Conciatori, Fabiana, et al.
Publicado: (2022)

From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
por: Guerrisi, Antonino, et al.
Publicado: (2020)

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
por: Del Curatolo, Anais, et al.
Publicado: (2018)

PTEN: Multiple Functions in Human Malignant Tumors
por: Milella, Michele, et al.
Publicado: (2015)

The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response
por: Martelli, Alberto M., et al.
Publicado: (2019)

Cutaneous melanoma follow-up: appropriateness of requests for ultrasound tests – the S.Gallicano National Referral Centre Experience
por: Solivetti, Francesco M, et al.
Publicado: (2013)

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
por: Allegretti, Matteo, et al.
Publicado: (2021)

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
por: Milella, Michele, et al.
Publicado: (2017)

Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation
por: Valente, Davide, et al.
Publicado: (2022)

HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature
por: Solivetti, Francesco Maria, et al.
Publicado: (2014)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
por: Loria, Rossella, et al.
Publicado: (2022)

Physical and Dosimetric Optimization of Laser Equipment in Dermatology: A Preliminary Study
por: Soriani, A., et al.
Publicado: (2014)

Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status
por: De Luca, Assunta, et al.
Publicado: (2020)

Multi-omics approaches for precision obesity management: Potentials and limitations of omics in precision prevention, treatment and risk reduction of obesity
por: Woldemariam, Selam, et al.
Publicado: (2023)

Precision medicine in sepsis and septic shock: From omics to clinical tools
por: Ruiz-Rodriguez, Juan Carlos, et al.
Publicado: (2022)

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
por: Bazzichetto, Chiara, et al.
Publicado: (2022)

Are We Ready to Use the Omics Strategies for Precision Medicine?
por: Kim, Jayoung
Publicado: (2016)

The Need for Multi-Omics Biomarker Signatures in Precision Medicine
por: Olivier, Michael, et al.
Publicado: (2019)

Editorial: Multi-omics studies and applications in precision medicine
por: Everad John, Arivusudar
Publicado: (2022)

Towards precision medicine: Omics approach for COVID-19
por: Cen, Xiaoping, et al.
Publicado: (2023)

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
por: Terrenato, Irene, et al.
Publicado: (2022)

Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol
por: Silvestris, Nicola, et al.
Publicado: (2022)

Adrenal Lesions: Spectrum of Imaging Findings with Emphasis on Multi-Detector Computed Tomography and Magnetic Resonance Imaging
por: Guerrisi, Antonino, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4od8hk6fpcghcr9sti177giajq